Candida albicans frequently cause oropharyngeal candidiasis in immunocompromised patients. As some of these isolates show resistance against azoles, the clinician is wary of initiating therapy with fluconazole (FZ) until a final susceptibility report is generated. We aimed to evaluate the efficacy of rapid flow cytometry (FCM) and disc diffusion (DD) methods in comparison to reference microdilution (MD) of Clinical and Laboratory Standards Institute (CLSI) method for FZ. Thirty seven Candida albicans isolates were tested by the three methods. By both MD and FCM, 26/37 (70.3%) were sensitive with minimal inhibitory concentration (MIC) 8 g/ml, 5/37 (13.5%) were susceptible dose dependant (S-DD) with MIC 16-32 g/ml and 6/37 (16.2%) were resistant with MIC 64 g/ml. More than 92% of isolates susceptible to FZ by the MD were susceptible by the DD methods with good agreement (81.08%, P = 0.000). However, 4/5 isolates diagnosed as S-DD by MD were resistant by DD. Interestingly, the MIC by FCM at 4 h showed excellent agreement (95.59%, P = 0.000) to that obtained by MD method at 24 h. Overall, FCM antifungal susceptibility testing provided rapid, reproducible results that are valuable alternative to MD. The DD test is recommended as a simple and reliable screening test for the detection of susceptible Candida albicans isolates to FZ.
INTRODUCTION
Oropharyngeal candidiasis is a common infection in cancer patients receiving therapies. The oral mucosal infection (ranging from 17 to 29%) with Candida albicans are particularly common in onco-hematological patients resulted in a higher risk for developing invasive candidiasis with an attributable mortality around 40% (23) . The "Clinical and Laboratory Standards Institute" (CLSI;
formerly NCCLS) Subcommittee on Antifungal Susceptibility
Tests has developed reproducible procedures for the antifungal susceptibility testing of yeasts for fluconazole by broth microdilution MD (documents M27-A2) method (3, 6) .
Because this method is time consuming, difficult to perform and labor intensive, alternative rapid and reliable methods are needed (19) . Agar based method as disk diffusion (DD) is attractive because of its simplicity and low-cost (1, 10) . CLSI had also established a DD procedure of yeasts for FZ (document M44-A) (7). Several years ago, it was suggested that flow cytometry (FCM) might be useful for susceptibility testing of micro-organisms, as drug-induced cell damage could be assessed by use of various fluorescent dyes on a cell-by-cell basis (20, 24 ) A rapid reliable susceptibility testing method would enable the clinician to prescribe the most suitable antifungal agent, thus avoiding more toxic or expensive therapy. In this aspect we aimed to evaluate the efficacy of rapid FCM and DD in comparison to reference MD method for FZ susceptibility testing of Candida albicans isolates. 
MATERIALS AND METHODS

Microorganisms
Procedures
1-Broth microdilution assay MD (document M27-A2):
The susceptibility assays were performed in sterile 96-well round bottom microplates as described previously. 
3-Disk diffusion procedure DD (document M44-A):
The adjusted inocula to 0. 
RESULTS
MICs of fluconazole (FZ) by broth micro-dilution (MD)
method were determined for 37 Candida albicans isolates after 24 h using the CLSI guidelines. Six of them (16%) were found to be resistant and 5 (13.5%) were S-DD (Table1).
El-Mashad, N. et al. (Table 3 ).
Susceptibility tests of oropharyngeal C. albicans
The levels of agreement between the MD and either DD or FCM (Table 4) showed that FCM was of excellent agreement while DD showed good agreement with a highly significant correlation (P; 0.000) The MD M27-A2 method revealed FZ resistance in 6 (16.2%) isolates while dose-depending susceptibility occurred in 5 (13.5%).
However, Enwuru et al., (9) informed that among 30
Candida albicans isolated from oropharyngeal HIV/AIDS patients, 26 (86.7%) were sensitive to FZ; 1 (3.3%) was S-DD and 3 (10%) were resistant. Wilheim et al., (27) reported that both, resistance (14.28%) and dose-depending susceptibility (4.76%) of esophageal candidiasis to FZ were considered high among immunocompromized patients.
In the present study, FCM technique, assayed by PI fluorescence emission, provides MD-comparable results for all 37 strains following a short period of incubation (4h).
It had been verified in other studies (21) (20), so it is understandable that the drug effects take at least a partial growth cycle to be detected.
We found mean channel fluorescence (MCF) to be a reliable parameter for all 37 strains tested. This is because FCM measures antibiotic-induced membrane damage. We used sodium deoxycholate to enhance diffusion of PI across the cell wall to pass through the damaged yeast cell membranes as recommended previously (21) .
Most previous studies of FZ defined the parameters of MIC by FCM as the drug concentration that produced a 50% increase in MCF (11, 19) . However, Joung et al. (12) demonstrated that a 50% increase in MCF might not be the best By using DD method, the majority of Candida strains (24/37) are susceptible to FZ and had a zone diameter above the breakpoint ( 19 mm), and these strains could safely be reported as susceptible. However, (2 / 37) susceptible strains, for which the MIC was 8 g/ml, were be reported as one resistant and one as S-DD by the DD.
. We could say that interpretation of resistant cases by DD method should be taken cautiously. This is similar to a study by Matar et al., (14) who !"
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In our study, the agreement between the DD and MD methods was 81% better than that reported previously (17) 
